Mankind Pharma announced that the Commissioner, CGST (Appeals), Meerut, has issued an order dated February 25, 2026. This order overturns a prior ruling concerning the Central Goods and Services Tax Act for financial years 2017-18 to 2020-21. Crucially, the appellate authority has approved the company’s appeal, resulting in the dropping of a substantial penalty amounting to INR 1,02,05,688/-. The detailed disclosure confirms no adverse impact on operations.
Major Relief in Indirect Tax Dispute
Mankind Pharma Limited has successfully secured relief concerning a significant tax matter pertaining to the Central Goods and Services Tax Act, 2017. The company received an Order-in-Appeal on February 25, 2026, issued by the office of the Commissioner, CGST (Appeals), Meerut, Uttar Pradesh.
Details of the Dropped Penalty
This appellate order relates to an appeal filed by Mankind Pharma against an earlier Order-in-Original dated December 27, 2024, passed by the Assistant Commissioner of Central Goods and Services Tax, Meerut.
The key outcome of the appeal ruling, which was dated January 28, 2026, is the complete dropping of a penalty demand amounting to INR 1,02,05,688/-. This penalty had been originally imposed under Section 74 of the CGST Act, 2017, concerning assessments for the financial years spanning 2017-18 through 2020-21.
Impact Assessment
As detailed in the accompanying Annexure-I disclosure, the violation or contravention alleged by the tax authority is marked as N.A. (Not Applicable) in the context of this favorable ruling. Furthermore, the management has confirmed that the outcome of this specific order will have N.A. impact on the financial, operational, or other activities of the listed entity, as the financial impact is effectively nullified by the penalty being dropped.
Source: BSE
